Safety and efficacy of semaglutide in post kidney transplant patients with type 2 diabetes or Post-Transplant diabetes

Letter to the Editor in response to the article “Semaglutide and post kidney transplantation in patients with diabetes”

“…We carefully read the article by Mahzari et al on the safety and efficacy of semaglutide in patients with post-kidney transplant patients with T2DM (T2DM) or Post-Transplant Diabetes Mellitus (PTDM) [1] . We applaud the authors for their innovative clinical practice in exploring the use of semaglutide in this patient population, and their proactive documentation of their experience in publishing this to the clinical and scientific community.…”